Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Women with PCOS have more severe liver disease.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Many men misuse oral contraceptive pills for things like hair growth and muscle gain.

Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Tamoxifen effectively treats gynecomastia without causing impotence.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Tamoxifen caused hair loss in a 52-year-old woman.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Including androgens in hormone therapy may lower breast cancer risk.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Some gonadal hormone drugs can block filovirus entry into cells.

Keratin 75 is important for fast wound healing and works with SOX2 and the LINC complex to help skin cells move and repair damage.